Tag:
Cerenis Therapeutics
Latest Headlines
Latest Headlines
Big Pharma has eyes on Cerenis' HDL drug
Tiny French drug developer Cerenis has begun mid-stage trials of a new class of drug that behaves like high-density lipoprotein (HDL)--the good cholesterol that can clear arteries of the plaque that
Cerenis lands $65M for mid-stage cholesterol drug program
Cerenis Therapeutics has nailed down $51.5 million in the first close of its Series C round, fueling the developer's mid-stage clinical trial for its lead cholesterol therapy and positioning the
ActoGeniX garners $17M in second round
Belgium's ActoGenix has returned to the venture capital well for $17 million in fresh funds. The fledgling developer is a spin-off of VIB and Ghent University. And it says it expects to see a
